Adipose Stem & Regenerative Cells Not Linked to Arrhythmias in Preclinical Study
Important Safety Findings Published in EuroPace Cardiology Journal
Arrhythmias are irregular heart rhythms that are common following heart attacks and can result in potentially life threatening complications.
"This is a significant safety finding, indicating that freshly isolated, uncultured, adipose-derived stem and regenerative cells did not promote arrhythmias after a heart attack," said Kai Pinkernell, M.D., head of research at Cytori. "The results are important to Cytori because the cells used in this study approximate the output of our bedside cell processing device, The Celution(TM) System, which is currently in clinical testing in Europe for the treatment of heart disease. Furthermore, it favorably distinguishes adipose tissue from other sources of cells used in cell therapy, some of which have been reported to potentially increase the incidence of arrhythmias."
As part of this study, adipose stem and regenerative cells or a saline control injection were administered into infarcted subjects. The improvements in ejection fraction, capillary density and perfusion defect were reported earlier, in a study designated by Cytori as the Tulane II Study. In addition, heart rhythms were monitored throughout an eight week period. At no point during this time was a difference in irregular heartbeats between both groups observed, indicating cell treated animals do not show an increase in potentially fatal arrhythmias. Conversely, at the end of the study period, the data suggest more electrophysiologic stimulation is required to experimentally and artificially induce arrhythmias in the cell treated group compared to the control group.
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.